Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal

E. Scott Monrad, D. S. Baim, H. S. Smith

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

To assess the long-term efficacy of milrinone in patients with severe congestive heart failure, we obtained hemodynamic measurements (systemic arterial and right heart catheterization) in 13 patients at baseline and after intravenous administration of milrinone. After continuous oral milrinone therapy of 8 ± 4 months duration, repeat hemodynamic study was performed in patients on oral milrinone therapy, after withdrawal of milrinone, and after readministration of milrinone intravenously. Comparison of initial baseline and withdrawal hemodynamic measurements for the group as a whole showed no interval progression of heart failure, as reflected by the pulmonary capillary wedge pressure (27 ± 8 to 24 ± 12 mm Hg, NS) or the cardiac index (2.0 ± 0.4 to 2.1 ± 0.8 liters/min/m2, NS). Individual comparisons of milrinone-free hemodynamics revealed that five patients had improved hemodynamically, three patients were unchanged, and five patients had deteriorated, four of whom manifested dependence on milrinone with a progressive hemodynamic decline after milrinone withdrawal which required readministration of milrinone on an emergency basis. Continued efficacy of milrinone was observed on readmission after withdrawal: pulmonary capillary wedge pressure fell from 27 ± 8 to 16 ± 10 mm Hg (p = .001) initially and from 24 ± 12 to 13 ± 11 mm Hg (p = .001) at readministration, while cardiac index rose from 2.0 ± 0.4 to 2.8 ± 0.5 liters/min/m2 (p = .001) initially and from 2.1 ± 0.8 to 2.7 ± 0.5 liters/min/m2 (p = .005) upon readministration. Long-term therapy with oral milrinone in these patients was not associated with an accelerated rate of progression in underlying heart failure, and there was no evidence of the development of tachyphylaxis to milrinone.

Original languageEnglish (US)
JournalCirculation
Volume73
Issue number3 II MONOGR. 120
StatePublished - 1986
Externally publishedYes

Fingerprint

Milrinone
Hemodynamics
Therapeutics
Pulmonary Wedge Pressure
Heart Failure
Tachyphylaxis
Cardiac Catheterization
Intravenous Administration

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. / Monrad, E. Scott; Baim, D. S.; Smith, H. S.

In: Circulation, Vol. 73, No. 3 II MONOGR. 120, 1986.

Research output: Contribution to journalArticle

Monrad, E. Scott ; Baim, D. S. ; Smith, H. S. / Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal. In: Circulation. 1986 ; Vol. 73, No. 3 II MONOGR. 120.
@article{8cb92041922e4d2cbb4ad08552b890bd,
title = "Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal",
abstract = "To assess the long-term efficacy of milrinone in patients with severe congestive heart failure, we obtained hemodynamic measurements (systemic arterial and right heart catheterization) in 13 patients at baseline and after intravenous administration of milrinone. After continuous oral milrinone therapy of 8 ± 4 months duration, repeat hemodynamic study was performed in patients on oral milrinone therapy, after withdrawal of milrinone, and after readministration of milrinone intravenously. Comparison of initial baseline and withdrawal hemodynamic measurements for the group as a whole showed no interval progression of heart failure, as reflected by the pulmonary capillary wedge pressure (27 ± 8 to 24 ± 12 mm Hg, NS) or the cardiac index (2.0 ± 0.4 to 2.1 ± 0.8 liters/min/m2, NS). Individual comparisons of milrinone-free hemodynamics revealed that five patients had improved hemodynamically, three patients were unchanged, and five patients had deteriorated, four of whom manifested dependence on milrinone with a progressive hemodynamic decline after milrinone withdrawal which required readministration of milrinone on an emergency basis. Continued efficacy of milrinone was observed on readmission after withdrawal: pulmonary capillary wedge pressure fell from 27 ± 8 to 16 ± 10 mm Hg (p = .001) initially and from 24 ± 12 to 13 ± 11 mm Hg (p = .001) at readministration, while cardiac index rose from 2.0 ± 0.4 to 2.8 ± 0.5 liters/min/m2 (p = .001) initially and from 2.1 ± 0.8 to 2.7 ± 0.5 liters/min/m2 (p = .005) upon readministration. Long-term therapy with oral milrinone in these patients was not associated with an accelerated rate of progression in underlying heart failure, and there was no evidence of the development of tachyphylaxis to milrinone.",
author = "Monrad, {E. Scott} and Baim, {D. S.} and Smith, {H. S.}",
year = "1986",
language = "English (US)",
volume = "73",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "3 II MONOGR. 120",

}

TY - JOUR

T1 - Assessment of long-term therapy with milrinone and the effects of milrinone withdrawal

AU - Monrad, E. Scott

AU - Baim, D. S.

AU - Smith, H. S.

PY - 1986

Y1 - 1986

N2 - To assess the long-term efficacy of milrinone in patients with severe congestive heart failure, we obtained hemodynamic measurements (systemic arterial and right heart catheterization) in 13 patients at baseline and after intravenous administration of milrinone. After continuous oral milrinone therapy of 8 ± 4 months duration, repeat hemodynamic study was performed in patients on oral milrinone therapy, after withdrawal of milrinone, and after readministration of milrinone intravenously. Comparison of initial baseline and withdrawal hemodynamic measurements for the group as a whole showed no interval progression of heart failure, as reflected by the pulmonary capillary wedge pressure (27 ± 8 to 24 ± 12 mm Hg, NS) or the cardiac index (2.0 ± 0.4 to 2.1 ± 0.8 liters/min/m2, NS). Individual comparisons of milrinone-free hemodynamics revealed that five patients had improved hemodynamically, three patients were unchanged, and five patients had deteriorated, four of whom manifested dependence on milrinone with a progressive hemodynamic decline after milrinone withdrawal which required readministration of milrinone on an emergency basis. Continued efficacy of milrinone was observed on readmission after withdrawal: pulmonary capillary wedge pressure fell from 27 ± 8 to 16 ± 10 mm Hg (p = .001) initially and from 24 ± 12 to 13 ± 11 mm Hg (p = .001) at readministration, while cardiac index rose from 2.0 ± 0.4 to 2.8 ± 0.5 liters/min/m2 (p = .001) initially and from 2.1 ± 0.8 to 2.7 ± 0.5 liters/min/m2 (p = .005) upon readministration. Long-term therapy with oral milrinone in these patients was not associated with an accelerated rate of progression in underlying heart failure, and there was no evidence of the development of tachyphylaxis to milrinone.

AB - To assess the long-term efficacy of milrinone in patients with severe congestive heart failure, we obtained hemodynamic measurements (systemic arterial and right heart catheterization) in 13 patients at baseline and after intravenous administration of milrinone. After continuous oral milrinone therapy of 8 ± 4 months duration, repeat hemodynamic study was performed in patients on oral milrinone therapy, after withdrawal of milrinone, and after readministration of milrinone intravenously. Comparison of initial baseline and withdrawal hemodynamic measurements for the group as a whole showed no interval progression of heart failure, as reflected by the pulmonary capillary wedge pressure (27 ± 8 to 24 ± 12 mm Hg, NS) or the cardiac index (2.0 ± 0.4 to 2.1 ± 0.8 liters/min/m2, NS). Individual comparisons of milrinone-free hemodynamics revealed that five patients had improved hemodynamically, three patients were unchanged, and five patients had deteriorated, four of whom manifested dependence on milrinone with a progressive hemodynamic decline after milrinone withdrawal which required readministration of milrinone on an emergency basis. Continued efficacy of milrinone was observed on readmission after withdrawal: pulmonary capillary wedge pressure fell from 27 ± 8 to 16 ± 10 mm Hg (p = .001) initially and from 24 ± 12 to 13 ± 11 mm Hg (p = .001) at readministration, while cardiac index rose from 2.0 ± 0.4 to 2.8 ± 0.5 liters/min/m2 (p = .001) initially and from 2.1 ± 0.8 to 2.7 ± 0.5 liters/min/m2 (p = .005) upon readministration. Long-term therapy with oral milrinone in these patients was not associated with an accelerated rate of progression in underlying heart failure, and there was no evidence of the development of tachyphylaxis to milrinone.

UR - http://www.scopus.com/inward/record.url?scp=0022649605&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022649605&partnerID=8YFLogxK

M3 - Article

C2 - 3510776

AN - SCOPUS:0022649605

VL - 73

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 3 II MONOGR. 120

ER -